Found: 14
Select item for more details and to access through your institution.
Suppression of RAD21 Induces Senescence of MDA-MB-231 Human Breast Cancer Cells Through RB1 Pathway Activation Via c-Myc Downregulation.
- Published in:
- Journal of Cellular Biochemistry, 2016, v. 117, n. 6, p. 1359, doi. 10.1002/jcb.25426
- By:
- Publication type:
- Article
TSA-induced JMJD2B downregulation is associated with cyclin B1-dependent survivin degradation and apoptosis in LNCap cells.
- Published in:
- Journal of Cellular Biochemistry, 2012, v. 113, n. 7, p. 2375, doi. 10.1002/jcb.24109
- By:
- Publication type:
- Article
CDK5 is essential for TGF-β1-induced epithelial-mesenchymal transition and breast cancer progression.
- Published in:
- Scientific Reports, 2013, p. 1, doi. 10.1038/srep02932
- By:
- Publication type:
- Article
High expression of miR-25 predicts favorable chemotherapy outcome in patients with acute myeloid leukemia.
- Published in:
- Cancer Cell International, 2019, v. 19, n. 1, p. N.PAG, doi. 10.1186/s12935-019-0843-9
- By:
- Publication type:
- Article
Anti-Proliferative Activity of HPOB against Multiple Myeloma Cells via p21 Transcriptional Activation.
- Published in:
- Molecules, 2018, v. 23, n. 5, p. 1044, doi. 10.3390/molecules23051044
- By:
- Publication type:
- Article
Identification of a Novel c-Myc Inhibitor 7594-0037 by Structure-Based Virtual Screening and Investigation of Its Anti-Cancer Effect on Multiple Myeloma.
- Published in:
- Drug Design, Development & Therapy, 2020, v. 14, p. 3983, doi. 10.2147/DDDT.S264077
- By:
- Publication type:
- Article
Novel dual-targeting c-Myc inhibitor D347-2761 represses myeloma growth via blocking c-Myc/Max heterodimerization and disturbing its stability.
- Published in:
- Cell Communication & Signaling, 2022, v. 20, n. 1, p. 1, doi. 10.1186/s12964-022-00868-6
- By:
- Publication type:
- Article
A novel 2-iminobenzimidazole compound, XYA1353, displays in vitro and in vivo anti-myeloma activity via targeting NF-κB signaling.
- Published in:
- Molecular & Cellular Biochemistry, 2024, v. 479, n. 4, p. 843, doi. 10.1007/s11010-023-04764-6
- By:
- Publication type:
- Article
Identification of Potential Prognostic Biomarker for Predicting Survival in Multiple Myeloma Using Bioinformatics Analysis and Experiments.
- Published in:
- Frontiers in Genetics, 2021, v. 12, p. 1, doi. 10.3389/fgene.2021.722132
- By:
- Publication type:
- Article
The selective HDAC6 inhibitor Nexturastat A induces apoptosis, overcomes drug resistance and inhibits tumor growth in multiple myeloma.
- Published in:
- Bioscience Reports, 2019, v. 39, n. 3, p. 1, doi. 10.1042/BSR20181916
- By:
- Publication type:
- Article
Identification of a novel c-Myc inhibitor with antitumor effects on multiple myeloma cells.
- Published in:
- Bioscience Reports, 2018, v. 38, n. 5, p. 1, doi. 10.1042/BSR20181027
- By:
- Publication type:
- Article
Pretreatment neutrophil/lymphocyte ratio but not platelet/lymphocyte ratio has a prognostic impact in multiple myeloma.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Blockade of deubiquitinase USP7 overcomes bortezomib resistance by suppressing NF‐κB signaling pathway in multiple myeloma.
- Published in:
- Journal of Leukocyte Biology, 2018, v. 104, n. 6, p. 1105, doi. 10.1002/JLB.2A1017-420RR
- By:
- Publication type:
- Article
Lysines 207 and 325 methylation of WDR5 catalyzed by SETD6 promotes breast cancer cell proliferation and migration.
- Published in:
- Oncology Reports, 2018, v. 40, n. 5, p. 3069, doi. 10.3892/or.2018.6669
- By:
- Publication type:
- Article